Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Use of darunavir/ritonavir once daily in treatment-naive pregnant woman: pharmacokinetics, compartmental exposure, efficacy and safety.

× No keyword cloud information.

7 in total

1. Salvage Regimens Containing Darunavir, Etravirine, Raltegravir, or Enfuvirtide in Highly Treatment-Experienced Perinatally Infected Pregnant Women.

Authors: Gail F Shust; Jennifer Jao; Gabriela Rodriguez-Caprio; Roberto Posada; Katherine T Chen; Amelia Averitt; Rhoda S Sperling
Journal: J Pediatric Infect Dis Soc Date: 2013-04-12 Impact factor: 3.164

2. Placental transfer of darunavir in an ex vivo human cotyledon perfusion model.

Authors: Laurent Mandelbrot; Dominique Duro; Emilie Belissa; Gilles Peytavin
Journal: Antimicrob Agents Chemother Date: 2014-06-30 Impact factor: 5.191

3. Pharmacokinetics of Once Versus Twice Daily Darunavir in Pregnant HIV-Infected Women.

Authors: Alice Stek; Brookie M Best; Jiajia Wang; Edmund V Capparelli; Sandra K Burchett; Regis Kreitchmann; Kittipong Rungruengthanakit; Tim R Cressey; Lynne M Mofenson; Elizabeth Smith; David Shapiro; Mark Mirochnick
Journal: J Acquir Immune Defic Syndr Date: 2015-09-01 Impact factor: 3.731

7. Total and unbound darunavir pharmacokinetics in pregnant women infected with HIV-1: results of a study of darunavir/ritonavir 600/100 mg administered twice daily.

Authors: C D Zorrilla; R Wright; O O Osiyemi; S Yasin; B Baugh; K Brown; B Coate; P Verboven; J Mrus; R Falcon; T N Kakuda
Journal: HIV Med Date: 2013-06-03 Impact factor: 3.180

7 in total

Use of darunavir/ritonavir once daily in treatment-naive pregnant woman: pharmacokinetics, compartmental exposure, efficacy and safety.

1. Salvage Regimens Containing Darunavir, Etravirine, Raltegravir, or Enfuvirtide in Highly Treatment-Experienced Perinatally Infected Pregnant Women.

2. Placental transfer of darunavir in an ex vivo human cotyledon perfusion model.

3. Pharmacokinetics of Once Versus Twice Daily Darunavir in Pregnant HIV-Infected Women.

Review 4. Overcoming pharmacologic sanctuaries.

Review 5. HIV protease inhibitors in pregnancy : pharmacology and clinical use.

Review 6. Protecting the fetus against HIV infection: a systematic review of placental transfer of antiretrovirals.

7. Total and unbound darunavir pharmacokinetics in pregnant women infected with HIV-1: results of a study of darunavir/ritonavir 600/100 mg administered twice daily.